Long-term patency rate for radial artery vs. saphenous vein grafts using same-patient materials

Mitsumasa Hata1, Isamu Yoshitake, Shinji Wakui

  • 1Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan. mihata@med.nihon-u.ne.jp

Insights

Long-term graft patency for radial artery (RA) and saphenous vein (SV) used in coronary artery bypass grafting showed similar 8-year results. RA showed poorer outcomes in patients with specific conditions, highlighting the need for tailored treatment strategies.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Grafting
  • Coronary Artery Bypass Grafting (CABG)

Background:

  • Radial artery (RA) and saphenous vein (SV) are commonly used conduits in CABG.
  • Assessing long-term patency differences between RA and SV is crucial for surgical decision-making.

Purpose of the Study:

  • To compare the long-term graft patency rates of the radial artery (RA) versus the saphenous vein (SV).
  • To identify independent predictors of graft failure for both RA and SV in patients undergoing CABG.

Main Methods:

  • A cohort of 318 patients undergoing CABG using both RA and SV was followed for 8 years.
  • Graft patency was assessed via angiography or multi-slice computed tomography in 192 patients.
  • Statistical analysis identified predictors of graft failure for each vessel type.

Main Results:

  • At 8 years, cumulative graft patency was 74.3% for RA and 64.7% for SV, with no significant difference.
  • Predictors of RA graft failure included native coronary stenosis <75% and peripheral vascular disease (PVD).
  • Predictors of SV graft failure included use of a single anti-platelet agent and a high LDL/HDL ratio (>2.5).

Conclusions:

  • Radial artery and saphenous vein grafts demonstrate similar long-term patency rates at 8 years post-CABG.
  • Radial artery grafts performed less favorably in patients with target vessel stenosis <75% and co-existing PVD.
  • Optimizing anti-platelet therapy and lipid management may enhance long-term saphenous vein graft patency.
Abstract